PolyPeptide Group AG (XSWX:PPGN) Total Liabilities : CHF290.3 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Total Liabilities?

PolyPeptide Group AG's Total Liabilities for the quarter that ended in Dec. 2023 was CHF290.3 Mil.

PolyPeptide Group AG's quarterly Total Liabilities increased from Dec. 2022 (CHF152.08 Mil) to Jun. 2023 (CHF199.79 Mil) and increased from Jun. 2023 (CHF199.79 Mil) to Dec. 2023 (CHF290.34 Mil).

PolyPeptide Group AG's annual Total Liabilities declined from Dec. 2021 (CHF180.94 Mil) to Dec. 2022 (CHF152.08 Mil) but then increased from Dec. 2022 (CHF152.08 Mil) to Dec. 2023 (CHF290.34 Mil).

PolyPeptide Group AG Total Liabilities Historical Data

The historical data trend for PolyPeptide Group AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Total Liabilities Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

170.02

214.34

180.94

152.08

290.34

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial					180.94	155.83	152.08	199.79	290.34

PolyPeptide Group AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PolyPeptide Group AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	166.406	+	(64.088	+	36.162
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	23.682)
	=	290.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	649.862	-	359.524
	=	290.3

PolyPeptide Group AG's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	166.406	+	(64.088	+	36.162
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	23.682)
	=	290.3

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	649.862	-	359.524
	=	290.3

PolyPeptide Group AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines